These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24112533)

  • 1. Plasma D-dimer concentrations during experimental EHV-1 infection of horses.
    Goehring LS; Soboll Hussey G; Gomez Diez M; Benedict K; Maxwell LK; Morley PS; Sloet van Oldruitenborgh-Oosterbaan MM; Lunn DP
    J Vet Intern Med; 2013; 27(6):1535-42. PubMed ID: 24112533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
    Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
    Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.
    Burgess BA; Tokateloff N; Manning S; Lohmann K; Lunn DP; Hussey SB; Morley PS
    J Vet Intern Med; 2012; 26(2):384-92. PubMed ID: 22332764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the host immune response on the development of equine herpesvirus myeloencephalopathy in horses.
    Giessler KS; Goehring LS; Jacob SI; Davis A; Esser MM; Lee Y; Zarski LM; Weber PSD; Hussey GS
    J Gen Virol; 2024 May; 105(5):. PubMed ID: 38767608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
    Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
    Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation parameters following equine herpesvirus type 1 infection in horses.
    Wilson ME; Holz CL; Kopec AK; Dau JJ; Luyendyk JP; Soboll Hussey G
    Equine Vet J; 2019 Jan; 51(1):102-107. PubMed ID: 29658149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1.
    Allen GP; Breathnach CC
    Equine Vet J; 2006 May; 38(3):252-7. PubMed ID: 16706281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
    Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
    Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
    Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
    Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.
    Schnabel CL; Wimer CL; Perkins G; Babasyan S; Freer H; Watts C; Rollins A; Osterrieder N; Wagner B
    BMC Vet Res; 2018 Aug; 14(1):245. PubMed ID: 30134896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of equid herpesvirus-1 reactivation and viremia in hospitalized critically ill horses.
    Carr E; Schott H; Pusterla N
    J Vet Intern Med; 2011; 25(5):1190-3. PubMed ID: 21848945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deletion of the ORF1 and ORF71 genes reduces virulence of the neuropathogenic EHV-1 strain Ab4 without compromising host immunity in horses.
    Wimer CL; Schnabel CL; Perkins G; Babasyan S; Freer H; Stout AE; Rollins A; Osterrieder N; Goodman LB; Glaser A; Wagner B
    PLoS One; 2018; 13(11):e0206679. PubMed ID: 30440016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Host Factors Associated with the Development of Equine Herpesvirus Myeloencephalopathy by Transcriptomic Analysis of Peripheral Blood Mononuclear Cells from Horses.
    Zarski LM; Giessler KS; Jacob SI; Weber PSD; McCauley AG; Lee Y; Soboll Hussey G
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33668216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine interferons following exposure to equid herpesvirus-1 or -4.
    Edington N; Bridges CG; Griffiths L
    J Interferon Res; 1989 Aug; 9(4):389-92. PubMed ID: 2474039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.